Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/12495909

Download in:

View as

General Info

PMID
12495909